All Articles on COVID-19
‘Fighting back’ against COVID-19: Remembering a historic trialLisa Jackson, MD, MPH, Kaiser Permanente Washington senior investigator, recounts the genesis of a groundbreaking vaccine.
Drugs, diabetes, and disparities: Studying COVID-19 risk and outcomesDr. Sascha Dublin tells how studies of KP electronic health record data can improve COVID-19 treatment and prevention.
Youth under 18 eligible for COVID vaccine trial registryA registry started by KPWHRI last year has sped up studies needed to protect the world against the novel coronavirus.
COVID-safe exercise ideas for older adults this winterTake these tips from researchers on the Society of Behavioral Medicine’s Physical Activity Special Interest Group.
KP biostatisticians help monitor COVID-19 vaccine safetyDr. Jennifer Nelson explains how Kaiser Permanente scientists are helping the CDC and FDA keep an eye out for rare adverse events.
Cancer screening in the time of COVID-19Dr. Diana Buist reflects on the challenges of providing screening during a pandemic — and finds reason for optimism.
NIH-Moderna COVID-19 vaccine receives FDA Emergency Use AuthorizationThe investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.